SNDK Soars 45.9% After EPS Revision, AI Memory Boom Fuels Rally
Sandisk (SNDK) led the gains, jumping 45.9% to $1,786.85 following an EPS revision and analyst target hikes, while Calumet (CLMT) rose 22.5% on strong base oil market dynamics. Aurora Cannabis (ACB) gained 20.4% on EPS growth of 161.8%, and Nabors (NBR) and Reed's (REED) posted double-digit gains driven by EPS revisions and operational improvements.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| SNDK | Technology | 2026-08-10 | N/A | +45.9% |
| CLMT | Basic Materials | 2026-08-09 | +11.7pp | +22.5% |
| ACB | Healthcare | 2026-08-09 | N/A | +20.4% |
| NBR | Energy | 2026-08-09 | +1.8pp | +18.5% |
| REED | Consumer Defensive | 2026-08-13 | +12.5pp | +16.3% |
Why did SNDK stock jump in August 2026?
Sandisk jumped 45.9% (from $1,224.78 to $1,786.85) after its next-year EPS growth estimate was revised to 25.5% on August 10.
The rally accelerated on August 17 when JPMorgan initiated coverage with a $2,250 target and Citi maintained a $2,100 target. The stock is riding the AI infrastructure boom, with management projecting 15% annual revenue growth and 80%+ gross margins through 2030. Screener detection caught the move early, and the market confirmed the EPS revision with strong price action.
SNDK EPS revision history → · Screener snapshot from 2026-08-10 →
FAQ: SNDK
Why did SNDK stock jump in August 2026?
SNDK jumped 45.9% after EPS growth estimates were revised to 25.5% and analysts raised price targets, citing AI memory demand and strong 2030 growth projections.
Is SNDK a buy after the rally?
Analysts are bullish, with JPMorgan setting a $2,250 target (26% upside) and Evercore ISI at $2,800, but the GF Score of 51/100 suggests caution on valuation.
What is SNDK's EPS growth estimate?
Sandisk's next-year EPS growth estimate is 25.5%, reflecting strong profitability expected from AI-driven memory demand.
Why did CLMT stock jump in August 2026?
Calumet jumped 22.5% (from $39.48 to $48.35) after its next-year EPS growth estimate was revised upward by 11.7 points to 170.8% on August 9.
The Q2 earnings call on August 8 revealed $175 million adjusted EBITDA despite planned turnarounds, driven by a structurally imbalanced base oil market with over 10% of global capacity offline. The company also cut leverage below 4x and confirmed MaxSAF 150 expansion, boosting investor confidence. The screener caught the revision early, and the market's positive response validated the earnings outlook.
CLMT EPS revision history → · Screener snapshot from 2026-08-09 →
FAQ: CLMT
Why did CLMT stock jump in August 2026?
CLMT jumped 22.5% after an upward EPS revision to 170.8% growth, supported by strong Q2 EBITDA and a favorable base oil market.
Is CLMT a buy after the rally?
CLMT's leverage reduction and high-margin specialty model are positive, but the soaring EPS estimate suggests pricing in aggressive growth; review valuation carefully.
What is CLMT's EPS growth estimate?
Calumet's next-year EPS growth estimate is 170.8%, revised up from 159.1%.
Why did ACB stock jump in August 2026?
Aurora Cannabis rose 20.4% (from $2.99 to $3.60) after its next-year EPS growth estimate was set at 161.8% on August 9.
The August 10 shareholder meeting results showed strong support, including 82.97% 'Say-on-Pay' approval, reinforcing management's medical-first strategy. The company's global leadership in medical cannabis and focus on long-term value likely contributed to the positive sentiment. The screener's detection of the EPS revision preceded the price gain, suggesting market confirmation of the growth outlook.
ACB EPS revision history → · Screener snapshot from 2026-08-09 →
FAQ: ACB
Why did ACB stock jump in August 2026?
ACB gained 20.4% after an EPS growth revision to 161.8%, supported by shareholder meeting outcomes and a reaffirmed medical-first strategy.
Is ACB a buy after the rally?
ACB's EPS estimate implies strong growth, but high volatility in cannabis stocks warrants careful risk assessment before buying.
What is ACB's EPS growth estimate?
Aurora Cannabis's next-year EPS growth estimate is 161.8%.
Why did NBR stock jump in August 2026?
Nabors Industries climbed 18.5% (from $81.59 to $96.71) after its next-year EPS growth estimate was revised to 275.0% on August 9.
No specific news catalyst was reported, but the upward revision likely reflects improved energy sector dynamics and operational efficiency. The screener identified the EPS estimate change early, and the subsequent price gain indicates market confidence in the earnings outlook.
NBR EPS revision history → · Screener snapshot from 2026-08-09 →
FAQ: NBR
Why did NBR stock jump in August 2026?
NBR jumped 18.5% after an upward EPS revision to 275.0% growth, likely driven by positive sector trends, though no specific news was released.
Is NBR a buy after the rally?
NBR's EPS estimate shows exceptional growth, but the absence of news suggests the move may be sentiment-driven; assess oil price stability.
What is NBR's EPS growth estimate?
Nabors's next-year EPS growth estimate is 275.0%, revised up from 273.1%.
Why did REED stock jump in August 2026?
Reed's shares rose 16.3% (from $0.92 to $1.07) after its next-year EPS growth estimate was revised upward by 12.5 points to 66.9% on August 13.
The Q2 earnings call on August 12 showed gross margin expanding from 8% to 24% and a 29% reduction in net loss, despite a 21% revenue decline. Investors focused on cost improvements and sequential sales growth, as management cited early traction from corrective actions. The EPS revision signaled improving profitability, and the market responded positively to the operational turnaround.
REED EPS revision history → · Screener snapshot from 2026-08-13 →
FAQ: REED
Why did REED stock jump in August 2026?
REED jumped 16.3% after an upward EPS revision to 66.9% growth, supported by sharp margin expansion and lower operating costs in Q2.
Is REED a buy after the rally?
REED's turnaround shows promise with improved margins, but revenue decline and cash position remain risks; evaluate before buying.
What is REED's EPS growth estimate?
Reed's next-year EPS growth estimate is 66.9%, revised up from 54.5%.
Today's top performers highlight a market rewarding upward EPS revisions, especially in AI-driven memory (SNDK) and specialty materials (CLMT). The broad-based gains across sectors suggest investors are prioritizing earnings growth potential over short-term noise.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →